15 May 2020
Arthritis Action invites you to take part in the new REUMAVID survey for people living with rheumatic diseases such as arthritis, experiencing confinement due to COVID-19.
The aim of the survey is to describe the consequences of the COVID-19 pandemic on the support services, healthcare, the quality of life and the emotional well-being of people living with rheumatic conditions.
Your responses will help develop solutions that will improve quality of life for people with rheumatic conditions, during the ongoing crisis.
You can complete the 25 minute survey here: https://es.surveymonkey.com/r/reumavid-UK
We are proud to be promoting this alongside the National Axial Spondyloarthritis Society (NASS) and National Rheumatoid Arthritis Society (NRAS). The questionnaire is being conducted by the Health & Territory Research (HTR) of the University of Seville, with the support of Novartis Pharma AG. The study is being conducted simultaneously in seven European countries (Cyprus, France, Greece, Italy, Portugal, Spain and the United Kingdom).